Company intelligence / Profile preview

Deep Blue Medical Advances

Durham, North Carolina, United States

Ownership: Private
Development stage: Other

Overview

Deep Blue Medical Advances is a privately held, active medical device company focused on developing and commercializing next-generation surgical devices and mesh for soft tissue and hernia surgery. Its flagship product, the T-Line Hernia Mesh, received FDA 510(k) clearance in 2020 and 2022 for hernia repair. The company also has a pipeline of innovative products for tissue reinforcement and mesh anchoring, all designed to address high rates of failure and recurrence in hernia and other soft tissue surgeries through superior anchoring and reinforcement.

Therapeutic areas: Women's HealthGastroenterologyOther
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Deep Blue Medical Advances.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deep Blue Medical Advances.

Explore the full profile